Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Packaging of Transdermal Patches

Posted on By

SOP for Packaging of Transdermal Patches

Standard Operating Procedure for Packaging of Transdermal Patches

1) Purpose

The purpose of this SOP is to define the process for packaging transdermal patches to ensure product integrity, protection, and compliance with regulatory standards.

2) Scope

This SOP applies to all packaging activities related to transdermal patches within the facility, covering the preparation, packaging process, labeling, and final inspection.

3) Responsibilities

The Packaging Department is responsible for carrying out the packaging process as per this SOP. The Packaging Manager ensures adherence to the procedure and maintains the necessary documentation.

See also  SOP for Moisture Content Testing in Transdermal Patches

4) Procedure

4.1 Preparation

  • 4.1.1 Verify the cleanliness and readiness of the packaging area and equipment.
  • 4.1.2 Ensure all packaging materials are available and meet the required specifications.
  • 4.1.3 Review the batch packaging record for completeness and accuracy.

4.2 Packaging Process

  • 4.2.1 Primary Packaging:
    • 4.2.1.1 Load the transdermal patches into the designated packaging machine.
    • 4.2.1.2 Operate the machine to seal each patch in its individual pouch or blister pack.
    • 4.2.1.3 Inspect the sealed packages for defects or damage.
  • 4.2.2 Secondary Packaging:
    • 4.2.2.1 Group the primary packaged units as per the packaging instructions.
    • 4.2.2.2 Place the grouped units into secondary cartons or boxes.
    • 4.2.2.3 Seal the cartons and label them appropriately.
See also  SOP for Adhesion Testing of Transdermal Patches

4.3 Labeling

  • 4.3.1 Verify the accuracy of all labels against the approved label copy.
  • 4.3.2 Affix labels to the
individual packages and secondary cartons as per the labeling instructions.
  • 4.3.3 Inspect the labeled packages for legibility and correctness.
  • 4.4 Final Inspection

    • 4.4.1 Conduct a final inspection of the packaged units for compliance with specifications.
    • 4.4.2 Document the inspection results in the packaging record.
    • 4.4.3 Approve the packaged batch for release or document any deviations.

    4.5 Documentation

    • 4.5.1 Complete the batch packaging record with all relevant details.
    • 4.5.2 Retain samples of the packaged product as per retention policy.
    • 4.5.3 Archive all packaging records as per regulatory requirements.

    5) Abbreviations, if any

    None

    6) Documents, if any

    Batch Packaging Record
    Label Copy Approval

    7) Reference, if any

    21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
    EU GMP Annex 15 – Qualification and Validation

    8) SOP Version

    Version 1.0

    See also  SOP for Training Personnel in Transdermal Patches Production
    Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

    Post navigation

    Previous Post: SOP for Pharmacovigilance Risk Communication
    Next Post: SOP for Labeling of Transdermal Patches

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version